1. Home
  2. STKH vs APVO Comparison

STKH vs APVO Comparison

Compare STKH & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STKH
  • APVO
  • Stock Information
  • Founded
  • STKH 2018
  • APVO 2016
  • Country
  • STKH Israel
  • APVO United States
  • Employees
  • STKH N/A
  • APVO N/A
  • Industry
  • STKH Packaged Foods
  • APVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • STKH Consumer Staples
  • APVO Health Care
  • Exchange
  • STKH Nasdaq
  • APVO Nasdaq
  • Market Cap
  • STKH 4.9M
  • APVO 5.4M
  • IPO Year
  • STKH 2021
  • APVO N/A
  • Fundamental
  • Price
  • STKH $0.98
  • APVO $1.38
  • Analyst Decision
  • STKH
  • APVO Strong Buy
  • Analyst Count
  • STKH 0
  • APVO 1
  • Target Price
  • STKH N/A
  • APVO $296.00
  • AVG Volume (30 Days)
  • STKH 16.0K
  • APVO 5.2M
  • Earning Date
  • STKH 03-31-2025
  • APVO 05-07-2025
  • Dividend Yield
  • STKH N/A
  • APVO N/A
  • EPS Growth
  • STKH N/A
  • APVO N/A
  • EPS
  • STKH N/A
  • APVO N/A
  • Revenue
  • STKH $10,000.00
  • APVO N/A
  • Revenue This Year
  • STKH N/A
  • APVO N/A
  • Revenue Next Year
  • STKH N/A
  • APVO N/A
  • P/E Ratio
  • STKH N/A
  • APVO N/A
  • Revenue Growth
  • STKH N/A
  • APVO N/A
  • 52 Week Low
  • STKH $0.92
  • APVO $0.94
  • 52 Week High
  • STKH $5.38
  • APVO $180.19
  • Technical
  • Relative Strength Index (RSI)
  • STKH 27.62
  • APVO 38.63
  • Support Level
  • STKH $0.92
  • APVO $0.94
  • Resistance Level
  • STKH $1.08
  • APVO $3.61
  • Average True Range (ATR)
  • STKH 0.10
  • APVO 0.53
  • MACD
  • STKH -0.01
  • APVO 0.02
  • Stochastic Oscillator
  • STKH 13.42
  • APVO 22.04

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industries through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: